Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajime Otsu

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2022
A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701Kazuma Kobayshi, Koichi Suyama, Hiroo Katsuya, et al.
Cancer Science|June 19, 2025
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC ExpressionKosuke Hirose, Takaaki Masuda, Hajime Otsu, et al.
Journal of Gastroenterology|April 20, 2026
Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinomaTomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 14, 2026
Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular CarcinomaKiyotaka Hosoda, Takaaki Masuda, Hideyuki Saito, et al.
Cancer Science|June 30, 2026
NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2Tomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Cancer Science|October 22, 2025
ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 ActivationTadashi Abe, Takaaki Masuda, Taro Tobo, et al.
Clinical and Translational Gastroenterology|January 29, 2021
Depressed Colorectal Cancer: A New Paradigm in Early Colorectal CancerShin-Ei Kudo, Yuta Kouyama, Yushi Ogawa, et al.
Plos Genetics|January 21, 2021
Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC casesShotaro Sakimura, Satoshi Nagayama, Mitsuko Fukunaga, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2022
A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701Kazuma Kobayshi, Koichi Suyama, Hiroo Katsuya, et al.
Cancer Science|June 19, 2025
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC ExpressionKosuke Hirose, Takaaki Masuda, Hajime Otsu, et al.
Journal of Gastroenterology|April 20, 2026
Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinomaTomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 14, 2026
Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular CarcinomaKiyotaka Hosoda, Takaaki Masuda, Hideyuki Saito, et al.
Cancer Science|June 30, 2026
NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2Tomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Cancer Science|October 22, 2025
ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 ActivationTadashi Abe, Takaaki Masuda, Taro Tobo, et al.
Clinical and Translational Gastroenterology|January 29, 2021
Depressed Colorectal Cancer: A New Paradigm in Early Colorectal CancerShin-Ei Kudo, Yuta Kouyama, Yushi Ogawa, et al.
Plos Genetics|January 21, 2021
Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC casesShotaro Sakimura, Satoshi Nagayama, Mitsuko Fukunaga, et al.
Pageof 5